inducement grants

BOTHELL, Wash., Feb. 6, 2026 — Immunome, Inc., a clinical-stage biotechnology company developing targeted oncology therapeutics, announced that its...

PRINCETON, N.J., December 5, 2025 — UroGen Pharma Ltd. has announced the issuance of inducement restricted stock units (RSUs)...